Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration

Emerging evidence suggests that bone marrow–derived endothelial, hematopoietic stem and progenitor cells contribute to tissue vascularization during both embryonic and postnatal physiological processes. Recent preclinical and pioneering clinical studies have shown that introduction of bone marrow–derived endothelial and hematopoietic progenitors can restore tissue vascularization after ischemic events in limbs, retina and myocardium. Corecruitment of angiocompetent hematopoietic cells delivering specific angiogenic factors facilitates incorporation of endothelial progenitor cells (EPCs) into newly sprouting blood vessels. Identification of cellular mediators and tissue-specific chemokines, which facilitate selective recruitment of bone marrow–derived stem and progenitor cells to specific organs, will open up new avenues of research to accelerate organ vascularization and regeneration. In addition, identification of factors that promote differentiation of the progenitor cells will permit functional incorporation into neo-vessels of specific tissues while diminishing potential toxicity to other organs. In this review, we discuss the clinical potential of vascular progenitor and stem cells to restore long-lasting organ vascularization and function.

[1]  J. Sampol,et al.  Cytofluorometric detection of human endothelial cells in whole blood using S-Endo 1 monoclonal antibody. , 1991, Journal of immunological methods.

[2]  S. Rafii,et al.  Vascular Trauma Induces Rapid but Transient Mobilization of VEGFR2+AC133+ Endothelial Precursor Cells , 2001, Circulation research.

[3]  S. Rafii,et al.  Vascular Endothelial Growth Factor and Angiopoietin-1 Stimulate Postnatal Hematopoiesis by Recruitment of Vasculogenic and Hematopoietic Stem Cells , 2001, The Journal of experimental medicine.

[4]  M. Entman,et al.  Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. , 2001, The Journal of clinical investigation.

[5]  H. Shepard,et al.  Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α , 1987, Nature.

[6]  S. Rafii,et al.  Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1+ stem cells from bone-marrow microenvironment , 2002, Nature Medicine.

[7]  R. Warnke,et al.  A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. , 1997, Blood.

[8]  D. Hanahan,et al.  MMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis , 2000, Cell.

[9]  S. Rafii,et al.  Interleukin‐1α (IL‐1α) promotes angiogenesis in vivo via VEGFR‐2 pathway by inducing inflammatory cell VEGF synthesis and secretion , 2002 .

[10]  K. Pantel,et al.  In vitro differentiation of endothelial cells from AC133-positive progenitor cells. , 1999, Blood.

[11]  D. McDonald,et al.  Time course of endothelial cell proliferation and microvascular remodeling in chronic inflammation. , 2001, The American journal of pathology.

[12]  S. Rafii,et al.  Trophic Effects of Platelets on Cultured Endothelial Cells are Mediated by Platelet-associated Fibroblast Growth Factor-2 (FGF-2) and Vascular Endothelial Growth Factor (VEGF) , 2002, Thrombosis and Haemostasis.

[13]  M. Pepper,et al.  Manipulating angiogenesis. From basic science to the bedside. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[14]  S. Homma,et al.  Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function , 2001, Nature Medicine.

[15]  P. Libby,et al.  Host bone-marrow cells are a source of donor intimal smooth- muscle–like cells in murine aortic transplant arteriopathy , 2001, Nature Medicine.

[16]  P. Gaulard,et al.  Erythroblasts are a source of angiogenic factors. , 2001, Blood.

[17]  J. Hillebrands,et al.  Origin of vascular smooth muscle cells and the role of circulating stem cells in transplant arteriosclerosis. , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[18]  Y. Mori,et al.  Angiogenesis by Implantation of Peripheral Blood Mononuclear Cells and Platelets Into Ischemic Limbs , 2002, Circulation.

[19]  David M. Bodine,et al.  Bone marrow cells regenerate infarcted myocardium , 2001, Nature.

[20]  J. Folkman,et al.  Isolation and characterization of endothelial progenitor cells from mouse embryos. , 1998, Development.

[21]  J. Isner,et al.  Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. , 1999, Circulation research.

[22]  Bernd Westphal,et al.  Autologous bone-marrow stem-cell transplantation for myocardial regeneration , 2003, The Lancet.

[23]  C. Verfaillie,et al.  Origin of endothelial progenitors in human postnatal bone marrow. , 2002, The Journal of clinical investigation.

[24]  Koichi Hattori,et al.  Young Adult Bone Marrow–Derived Endothelial Precursor Cells Restore Aging-Impaired Cardiac Angiogenic Function , 2002, Circulation research.

[25]  J. Isner,et al.  Bone Marrow as a Source of Endothelial Cells for Natural and Iatrogenic Vascular Repair , 2001, Annals of the New York Academy of Sciences.

[26]  F. Dieterlen‐Lièvre,et al.  Blood-borne seeding by hematopoietic and endothelial precursors from the allantois. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[27]  K. Alitalo,et al.  VEGF receptor 1 stimulates stem-cell recruitment and new hope for angiogenesis therapies , 2002, Nature Medicine.

[28]  Takayuki Asahara,et al.  Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.

[29]  M. Voskuil,et al.  Local Monocyte Chemoattractant Protein-1 Therapy Increases Collateral Artery Formation in Apolipoprotein E–Deficient Mice but Induces Systemic Monocytic CD11b Expression, Neointimal Formation, and Plaque Progression , 2003, Circulation research.

[30]  S. Rafii,et al.  Circulating endothelial precursors: mystery, reality, and promise. , 2000, The Journal of clinical investigation.

[31]  Yasuko Tomizawa,et al.  Autocrine angiogenic vascular prosthesis with bone marrow transplantation , 1996, Nature Medicine.

[32]  J. Kearney,et al.  AC133, a novel marker for human hematopoietic stem and progenitor cells. , 1997, Blood.

[33]  K. Shimada,et al.  Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial , 2002, The Lancet.

[34]  A. Luttun,et al.  Vascular progenitors: from biology to treatment. , 2002, Trends in cardiovascular medicine.

[35]  Y. Yoon,et al.  VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema. , 2003, The Journal of clinical investigation.

[36]  Michael Chopp,et al.  Bone Marrow-Derived Endothelial Progenitor Cells Participate in Cerebral Neovascularization After Focal Cerebral Ischemia in the Adult Mouse , 2002, Circulation research.

[37]  J. Hillebrands,et al.  Bone marrow does not contribute substantially to endothelial-cell replacement in transplant arteriosclerosis , 2002, Nature Medicine.

[38]  J. Isner,et al.  Statin Therapy Accelerates Reendothelialization: A Novel Effect Involving Mobilization and Incorporation of Bone Marrow-Derived Endothelial Progenitor Cells , 2002, Circulation.

[39]  Y. Yoon,et al.  Intramyocardial Transplantation of Autologous Endothelial Progenitor Cells for Therapeutic Neovascularization of Myocardial Ischemia , 2003, Circulation.

[40]  H. Blau,et al.  VEGF gene delivery to myocardium: deleterious effects of unregulated expression. , 2000, Circulation.

[41]  A. Gascoigne,et al.  Circulating endothelial cells in patients with septic shock. , 2001, American journal of respiratory and critical care medicine.

[42]  P. Polverini,et al.  Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages. , 1984, Laboratory investigation; a journal of technical methods and pathology.

[43]  J. Folkman,et al.  Therapeutic angiogenesis in ischemic limbs. , 1998, Circulation.

[44]  L. Sauvage,et al.  Enhanced endothelialization and microvessel formation in polyester grafts seeded with CD34(+) bone marrow cells. , 2000, Blood.

[45]  Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI) , 2002 .

[46]  R. Hebbel,et al.  Origins of circulating endothelial cells and endothelial outgrowth from blood. , 2000, The Journal of clinical investigation.

[47]  Anthony Atala,et al.  Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo , 2001, Nature Medicine.

[48]  A. Luttun,et al.  Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1 , 2002, Nature Medicine.

[49]  M. Makuuchi,et al.  Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis , 2002, Nature Medicine.

[50]  D. Ribatti,et al.  Hematopoiesis and angiogenesis: a link between two apparently independent processes. , 2000, Journal of hematotherapy & stem cell research.

[51]  L. Sauvage,et al.  Utilizing Granulocyte Colony-stimulating Factor to Enhance Vascular Graft Endothelialization from Circulating Blood Cells , 2002, Annals of vascular surgery.

[52]  E. Scott,et al.  Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion , 2002, Nature.

[53]  H. Dvorak,et al.  Angiogenesis Therapy: Amidst the Hype, the Neglected Potential for Serious Side Effects , 2001, Circulation.

[54]  A. Bihorac,et al.  Circulating endothelial cells: tea leaves for renal disease. , 2002, American journal of physiology. Renal physiology.

[55]  D. Soligo,et al.  Differentiation and expansion of endothelial cells from human bone marrow CD133+ cells , 2001, British journal of haematology.

[56]  G. Gurtner,et al.  Human Endothelial Progenitor Cells From Type II Diabetics Exhibit Impaired Proliferation, Adhesion, and Incorporation Into Vascular Structures , 2002, Circulation.

[57]  R. Weisel,et al.  Autologous transplantation of bone marrow cells improves damaged heart function. , 1999, Circulation.

[58]  D. Cheresh,et al.  The role of alphav integrins during angiogenesis: insights into potential mechanisms of action and clinical development. , 1999, The Journal of clinical investigation.

[59]  J. Isner,et al.  Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[60]  D. Bodine,et al.  Transplanted Adult Bone Marrow Cells Repair Myocardial Infarcts in Mice , 2001, Annals of the New York Academy of Sciences.

[61]  S. Rafii,et al.  Splitting vessels: Keeping lymph apart from blood , 2003, Nature Medicine.

[62]  Rong Zhou,et al.  Regulation of Blood and Lymphatic Vascular Separation by Signaling Proteins SLP-76 and Syk , 2003, Science.

[63]  S. Rafii,et al.  Impaired recruitment of bone-marrow–derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth , 2001, Nature Medicine.

[64]  D. McDonald,et al.  Tissue macrophages associated with angiogenesis in chronic airway inflammation in rats. , 1999, American journal of respiratory cell and molecular biology.

[65]  Peter Carmeliet,et al.  VEGF gene therapy: stimulating angiogenesis or angioma-genesis? , 2000, Nature Medicine.

[66]  J. Enenstein,et al.  Identification and functional assessment of endothelial P1H12. , 2001, The Journal of laboratory and clinical medicine.

[67]  D. Raoult,et al.  Diagnosis of Mediterranean spotted fever by indirect immunofluorescence of Rickettsia conorii in circulating endothelial cells isolated with monoclonal antibody-coated immunomagnetic beads. , 1992, The Journal of infectious diseases.

[68]  Hung-Fat Tse,et al.  Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation , 2003, The Lancet.

[69]  S. Fichtlscherer,et al.  Increase in Circulating Endothelial Progenitor Cells by Statin Therapy in Patients With Stable Coronary Artery Disease , 2001, Circulation.

[70]  E. Scott,et al.  Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization , 2002, Nature Medicine.

[71]  E. Raines,et al.  Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation. , 2000, Circulation research.

[72]  E. Popa,et al.  Origin of neointimal endothelium and alpha-actin-positive smooth muscle cells in transplant arteriosclerosis. , 2001, The Journal of clinical investigation.

[73]  P. Wernet,et al.  Repair of Infarcted Myocardium by Autologous Intracoronary Mononuclear Bone Marrow Cell Transplantation in Humans , 2002, Circulation.

[74]  P. Carmeliet,et al.  Angiogenesis in cancer and other diseases , 2000, Nature.

[75]  S. Rafii,et al.  VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular endothelial precursor cells. , 2003, Blood.

[76]  Neil D. Theise,et al.  Multi-Organ, Multi-Lineage Engraftment by a Single Bone Marrow-Derived Stem Cell , 2001, Cell.

[77]  S. Rafii,et al.  Brain derived neurotrophic factor is an endothelial cell survival factor required for intramyocardial vessel stabilization. , 2000, Development.

[78]  Shulamit Levenberg,et al.  Endothelial cells derived from human embryonic stem cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[79]  A. Kosaki,et al.  Implantation of Bone Marrow Mononuclear Cells Into Ischemic Myocardium Enhances Collateral Perfusion and Regional Function via Side Supply of Angioblasts, Angiogenic Ligands, and Cytokines , 2001, Circulation.

[80]  J. Isner,et al.  Therapeutic Potential of Ex Vivo Expanded Endothelial Progenitor Cells for Myocardial Ischemia , 2001, Circulation.

[81]  J. Isner.  Myocardial gene therapy , 2002, Nature.

[82]  M. Simons,et al.  Insights from angiogenesis trials using fibroblast growth factor for advanced arteriosclerotic disease. , 2003, Trends in cardiovascular medicine.

[83]  M. Sands,et al.  VEGF increases engraftment of bone marrow-derived endothelial progenitor cells (EPCs) into vasculature of newborn murine recipients , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[84]  R. Hynes.  A reevaluation of integrins as regulators of angiogenesis , 2002, Nature Medicine.

[85]  Haruchika Masuda,et al.  Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization , 1999, Nature Medicine.

[86]  M. Matsuzaki,et al.  Enhancement of angiogenesis by the implantation of self bone marrow cells in a rat ischemic heart model. , 2000, The Journal of surgical research.

[87]  W. Edwards,et al.  Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[88]  M. Skobe,et al.  Therapeutic lymphangiogenesis with human recombinant VEGF‐C , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[89]  M C Oz,et al.  Characterization of hematopoietic cells arising on the textured surface of left ventricular assist devices. , 1995, The Annals of thoracic surgery.

[90]  A. Palotie,et al.  Peripheral Blood Platelets Express VEGF-C and VEGF which Are Released during Platelet Activation , 1998, Thrombosis and Haemostasis.

[91]  S. Rafii,et al.  Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. , 2000, Blood.

[92]  J. Isner,et al.  Constitutive Human Telomerase Reverse Transcriptase Expression Enhances Regenerative Properties of Endothelial Progenitor Cells , 2002, Circulation.

[93]  S. Rafii,et al.  Molecular pathways regulating mobilization of marrow-derived stem cells for tissue revascularization. , 2003, Trends in molecular medicine.

[94]  T. Noda,et al.  A Role for Hematopoietic Stem Cells in Promoting Angiogenesis , 2000, Cell.

[95]  Federica Limana,et al.  Mobilized bone marrow cells repair the infarcted heart, improving function and survival , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[96]  W. Risau,et al.  Mechanisms of angiogenesis , 1997, Nature.

[97]  Qingbo Xu,et al.  Smooth Muscle Cells in Transplant Atherosclerotic Lesions Are Originated From Recipients, but Not Bone Marrow Progenitor Cells , 2002, Circulation.

[98]  W. Daniel,et al.  Monocytes coexpress endothelial and macrophagocytic lineage markers and form cord-like structures in Matrigel under angiogenic conditions. , 2001, Cardiovascular research.

[99]  I. Weissman,et al.  Little Evidence for Developmental Plasticity of Adult Hematopoietic Stem Cells , 2002, Science.

[100]  A M Zeiher,et al.  HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. , 2001, The Journal of clinical investigation.

[101]  E. Wayner,et al.  Circulating activated endothelial cells in sickle cell anemia. , 1997, The New England journal of medicine.

[102]  N. Weissman,et al.  Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. , 2001, Journal of the American College of Cardiology.

[103]  H. Matsubara,et al.  Improvement of Collateral Perfusion and Regional Function by Implantation of Peripheral Blood Mononuclear Cells Into Ischemic Hibernating Myocardium , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[104]  S. Rafii,et al.  Recruitment of Stem and Progenitor Cells from the Bone Marrow Niche Requires MMP-9 Mediated Release of Kit-Ligand , 2002, Cell.

[105]  J. Waltenberger,et al.  Vascular endothelial growth factor-A-induced chemotaxis of monocytes is attenuated in patients with diabetes mellitus: A potential predictor for the individual capacity to develop collaterals. , 2000, Circulation.

[106]  M. Karkkainen,et al.  Insights into the Molecular Pathogenesis and Targeted Treatment of Lymphedema , 2002, Annals of the New York Academy of Sciences.

[107]  S. Karpatkin,et al.  Identification of a family of alternatively spliced mRNA species of angiopoietin-1. , 2000, Blood.

[108]  D. Hanahan,et al.  Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.

[109]  M. Dake,et al.  Vascular endothelial growth factor enhances atherosclerotic plaque progression , 2001, Nature Medicine.

[110]  A. Nienhuis,et al.  Bone marrow-derived cells contribute to tumor neovasculature and, when modified to express an angiogenesis inhibitor, can restrict tumor growth in mice. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[111]  Jun Yamashita,et al.  Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors , 2000, Nature.

[112]  D. Hanahan,et al.  Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. , 1999, Science.

[113]  M. Moore.  Putting the neo into neoangiogenesis. , 2002, The Journal of clinical investigation.

[114]  Koichi Hattori,et al.  Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy? , 2002, Nature Reviews Cancer.

[115]  D. McDonald,et al.  Angiogenesis and remodeling of airway vasculature in chronic inflammation. , 2001, American journal of respiratory and critical care medicine.

[116]  L. Sauvage,et al.  Proof of fallout endothelialization of impervious Dacron grafts in the aorta and inferior vena cava of the dog. , 1994, Journal of vascular surgery.

[117]  J. Isner,et al.  VEGF contributes to postnatal neovascularization by mobilizing bone marrow‐derived endothelial progenitor cells , 1999, The EMBO journal.

[118]  Franklin Peale,et al.  Identification of an angiogenic mitogen selective for endocrine gland endothelium , 2001, Nature.

[119]  S. Rafii,et al.  Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[120]  James T. Willerson,et al.  Transendocardial, Autologous Bone Marrow Cell Transplantation for Severe, Chronic Ischemic Heart Failure , 2003, Circulation.

[121]  B. Christy,et al.  Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. , 2000, The Journal of clinical investigation.

[122]  J. Folkman.  Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.

[123]  Mark Ellisman,et al.  Human cord blood progenitors sustain thymic T-cell development and a novel form of angiogenesis. , 1999, Blood.

[124]  S. Rafii,et al.  Efficient mobilization and recruitment of marrow-derived endothelial and hematopoietic stem cells by adenoviral vectors expressing angiogenic factors , 2002, Gene Therapy.

[125]  S. Schwartz,et al.  Angioblast differentiation and morphogenesis of the vascular endothelium in the mouse embryo. , 1991, Developmental biology.

[126]  M A Konerding,et al.  Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. , 1999, Circulation.

[127]  Christie M. Orschell,et al.  Peripheral Blood “Endothelial Progenitor Cells” Are Derived From Monocyte/Macrophages and Secrete Angiogenic Growth Factors , 2003, Circulation.

[128]  Patrick W. Faloon,et al.  In vitro hematopoietic and endothelial potential of flk-1(-/-) embryonic stem cells and embryos. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[129]  J. Isner,et al.  Endothelial Progenitor Cell Vascular Endothelial Growth Factor Gene Transfer for Vascular Regeneration , 2002, Circulation.

[130]  D. Hess,et al.  Bone Marrow as a Source of Endothelial Cells and NeuN-Expressing Cells After Stroke , 2002, Stroke.

[131]  M. Goodell,et al.  Distinct progenitor populations in skeletal muscle are bone marrow derived and exhibit different cell fates during vascular regeneration. , 2003, The Journal of clinical investigation.

[132]  E. Unanue,et al.  Activated macrophages induce vascular proliferation , 1977, Nature.

[133]  P. Schimmel,et al.  Bone marrow–derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis , 2002, Nature Medicine.

[134]  K. Alitalo,et al.  Endothelial cells genetically selected from differentiating mouse embryonic stem cells incorporate at sites of neovascularization in vivo. , 2002, Journal of cell science.

[135]  S. Rafii,et al.  Evidence for circulating bone marrow-derived endothelial cells. , 1998, Blood.

[136]  Salman Rahman,et al.  Novel Vascular Endothelial Growth Factor Binding Domains of Fibronectin Enhance Vascular Endothelial Growth Factor Biological Activity , 2002, Circulation research.

[137]  T. Murohara,et al.  Mobilization of Endothelial Progenitor Cells in Patients With Acute Myocardial Infarction , 2001, Circulation.

[138]  A. Quyyumi,et al.  Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. , 2003, The New England journal of medicine.

[139]  J P Cazenave,et al.  Rapid Isolation of Human Endothelial Cells from Whole Blood Using S-Endo1 Monoclonal Antibody Coupled to Immuno-Magnetic Beads: Demonstration of Endothelial Injury after Angioplasty , 1992, Thrombosis and Haemostasis.

[140]  Philippe Leboulch,et al.  Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2 , 2003, Nature Medicine.

[141]  P. Polverini,et al.  Angiogenic macrophages produce the angiogenic inhibitor thrombospondin 1. , 1993, The American journal of pathology.

[142]  Stanley J. Wiegand,et al.  Vascular-specific growth factors and blood vessel formation , 2000, Nature.